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Abstract
Background. Brain tumours often present with varied, non-specific features with other diagnoses 
usually being more likely.
Objective. To examine how different symptoms and patient demographics predict variations in 
time to brain tumour diagnosis.
Methods. We conducted a secondary analysis of brain tumour cases from National Audit of Cancer 
Diagnosis in Primary Care. We grouped neurological symptoms into six domains (headache, 
behavioural/cognitive change, focal neurology, ‘fits, faints or falls’, non-specific neurological, and 
other/non-specific) and calculated times for patient presentation, GP referral, specialist consultation 
and total pathway interval. We calculated odds ratios (ORs) for symptom domains comparing the 
slowest to other quartiles.
Results. Data were available for 226 cases. Median (interquartile range) time for the total pathway 
interval was 24 days (7–65 days). The most common presentation was focal neurology (33.2%) 
followed by ‘fits, faints or falls’ and headache (both 20.8%). Headache only (OR = 4.11, 95% CI = 1.10, 
15.5) and memory complaints (OR = 4.82, 95% CI = 1.15, 20.1) were associated with slower total 
pathway compared to ‘fits, faints or falls’. GPs were more likely to consider that there had been 
avoidable delays in referring patients with headache only (OR = 4.17, 95% CI = 1.14, 15.3).
Conclusion. Patients presenting to primary care with headache only or with memory complaints 
remain problematic with potentially avoidable delays in referral leading to a longer patient 
pathway. This may or may not impact on the efficacy and morbidity of therapies. Additional aids are 
required to help doctors differentiate when to refer headaches and memory complaints urgently 
for a specialist opinion.
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Introduction
The incidence of brain tumours is low; age-adjusted incidence rates 
for all gliomas range from 4.7 to 5.7 per 100 000 persons (1). This 
means that the diagnosis of brain tumour is very rare in primary 
care populations. While the diagnosis of cancer is usually made 
in secondary care, most patients will have seen their GP prior to 
a diagnosis (2–4). Further, patients can present with a wide range 
of different symptoms which may be common (e.g. headache), 
non-threatening or may be thought of as part of a normal ageing 
process (e.g. memory loss). The non-specificity of these symptoms 
creates a diagnostic challenge for all clinical staff. Current guide-
lines in the UK recommend that all patients with suspected CNS tu-
mour must be seen by a specialist within 2 weeks of referral by their 
GP; despite the introduction of this guideline in 2005, there appears 
to have been little improvement in the diagnostic interval (5) (the 
time from first presentation with symptoms to diagnosis) over the 
last decade (6). Indeed, most recent figures show only 1% of cases 
with suspected brain tumour are diagnosed through the ‘suspected 
cancer’ 2-week wait process, while 17% are GP referrals through 
usual pathways, and 58% are diagnosed after an accident and emer-
gency attendance (7).
Several studies have examined case series of patients with brain 
tumours and have quantified the frequency of the most common pre-
senting symptoms (8,9); in some cases deriving predictive values by 
comparing this to age–sex matched control patients in primary care 
(10–15). A systematic review (16) found that all symptoms had in 
general low positive predictive values for brain tumours, apart from 
new-onset epilepsy. Few studies have investigated how symptoms 
may influence the time to diagnosis. The National Audit of Cancer 
Diagnosis in Primary Care (NACDPC) has previously found that 
around a third (35.2%) of patients with brain tumours took 15 days 
or more to present to their GP (17) and 21.4% of cases required 
three or more consultations before referral compared to 17.9% for 
all cancers or as little as 2.9% for breast cancer patients (18).
This study examines whether different clinical presentations are 
associated with variations in the patient pathway to diagnosis and 
where future interventions could be best targeted to reduce diag-
nostic delay and possibly improve patient prognosis.
Material and methods
Data
We analysed data from the (English) NACDPC (2009–2010). Data 
were collected from 18 879 patients by 1170 practices (~14% of 
all practices in England) in 20 cancer networks using an audit tem-
plate and information from their practice clinical records and hos-
pital correspondence. Any screen-detected or incidental cancers were 
excluded from the audit. Patient demographics and the information 
related to the assessment process in primary care were collected (for 
full details concerning the NACDPC methods, see the report by 
Royal College of General Practitioners) (19).
Outcomes
Only patients with a confirmed diagnosis of brain tumour (no details 
on specific pathology were available) were selected for this analysis. 
We examined time to four specific outcomes to try and understand 
the clinical pathway from symptom onset to specialist consultation 
(see Figure 1 for visual representation): (i) time from patient recog-
nition of symptoms until first GP consultation (‘patient interval’); 
(ii) time from first GP consultation until referral to specialist (‘pri-
mary care interval’); (iii) time from referral until specialist attend-
ance (‘specialist interval’); (iv) total time from patient recognition 
of symptoms until first specialist visit (sum of 1 and 2 and 3 above) 
(‘pathway interval’).
In addition, we looked at three other related outcomes that may 
indicate a suboptimal referral interval: (i) if the patient attended 
primary care three or more times before referral and (ii) the GP’s 
response to the following questions (a) ‘Would rapid access to inves-
tigations have altered your management of this case?’ and (b) ‘Were 
there any avoidable delays to this patient’s journey?’ In this latter 
case, GPs could respond ‘No’, ‘Yes’ or ‘Unsure’. Due to small num-
bers, we combined ‘Unsure’ and ‘No’ to create a binary outcome 
variable (‘Yes’ versus ’Unsure/No’). These last two variables are 
retrospective in nature.
Clinical symptoms
The information on patient records was collected by GPs or pri-
mary care professionals. We grouped individual symptoms into six 
domains based on categorizations of previous papers and the region 
of brain likely to be causing the symptom: intracerebral damage—
focal neurology; intracerebral damage—cognitive/behavioural; 
intracerebral excitation (seizure); intracranial extracerebral damage 
(cranial nerve); raised pressure (headache); and ‘non specific’ based 
on specialist opinions (PB, KZ, RG) (see supplementary table  1). 
We created the following domains: (i) headache; (ii) behavioural/
cognitive change; (iii) focal neurology including stroke; (iv) episodic 
attacks—‘fits, faints and falls’; (v) non-specific neurological; and 
(vi) other/non-specific features. Headache and behavioural/ cogni-
tive change were further divided into two subgroups: headache was 
divided into headache only and headache plus additional features 
recorded, whilst behavioural/cognitive change was divided into con-
fusion and memory only subgroups. If more than one symptom was 
recorded (other than for the headache plus group), we chose what 
we considered to be the main symptom for classification purposes.
Figure 1. The pathway and time to diagnosis for patients with brain tumour
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Other covariates
We also examined the following covariates: gender, age group (<60, 
60–70, >70 years), ethnicity (white British versus other), whether the 
patient had problems in communication, was housebound, whether 
the GP ordered investigations before referral, type of referral, where 
patients first presented, and which specialist was chosen for the 
referral.
Statistical analysis
We calculated the median (interquartile range) time to diagnosis (in 
days) according to patient, referral, specialist and pathway intervals 
by symptom domains, and other factors. As the time data were highly 
skewed, we derived a binary outcome variable indicating slower time 
interval by deriving quartiles and comparing patients in the slowest 
versus the other three quartiles. We compared each symptom domain 
relative to fits, faints and falls (baseline group) as this domain was 
associated with the shortest pathway interval.
We calculated odds ratios (ORs), 95% confidence intervals (CI) 
and P values using multivariable logistic regression and treating 
symptom domain as a dummy variable. We calculated crude and 
multivariable ORs, adjusting for age group, sex and ethnicity as 
these covariates are potential confounders as they may determine 
how symptoms are perceived by the patients and present to the GP 
as well as influencing the time to see GP and referral. Because of 
missing data for the time intervals, we undertook multiple imput-
ation using chained equations for our binary outcomes so that we 
could use all the cases in our logistic regression model. This analysis 
is potentially less biased due to missing data. The imputation model 
included all variables from our analysis model as well as covari-
ates shown in Table 1. We used 20 cycles for the chained equations 
and derived 10 imputed datasets, which were then combined using 
Rubin’s rules to derive the appropriate ORs, 95% CI and P values 
using the mi estimate command in Stata. The multivariable ORs are 
based on the imputed dataset to maximise statistical power, given the 
relatively small sample size.
Table 1. Sociodemographic characteristics of patients of brain tumour, n = 226
Variable Frequency % Frequency %
Age group Investigation before referral
<60 82 36.3 No 142 62.8
60–69 55 24.3 Yes 70 31.0
≥70 84 37.2 Unknown 14 6.2
Unknown 5 2.2
Which specialist to be referred
Sex Neurology 55 24.3
Female 105 46.5 Accident and emergency 18 8.0
Male 121 53.5 Medicine and geriatrics 50 22.1
Ophthalmology 17 7.5
Ethnicity Neurosurgery 19 8.4
White British 177 78.3 Paediatrics 11 4.9
Other 29 12.8 Stroke 9 4.0
Unknown 20 8.9 Miscellaneous 17 7.5
Unknown 30 13.3
Housebound
No 187 82.7 Type of referral
Yes 27 12.0 Emergency 90 39.82
Unknown 12 5.3 Not referred by practice 34 15.04
2 week/private 41 18.14
Problems in communication Routine 39 17.26
No 187 82.7 Unknown 22 9.73
Dementia 4 1.8
Language barrier 8 3.5 Attended 3+ before referral
Leaning difficulty 2 0.9 No 119 62.7
Mental Health 2 0.9 Yes 76 33.6
Poor vision 1 0.4 Unknown 31 13.7
Speech impediment 11 4.9
Unknown 11 4.9 Rapid access investigations
No 157 69.5
Symptoms Yes 46 20.4
Headache 47 20.8 Unknown 23 10.1
 Headache only 16
 Headache plus 31 Avoidable delays in patient journey
Behavioural/cognitive 28 12.4 No 153 67.7
 Confusion 14 Yes 68 30.1
 Memory 14 Unknown 5 2.2
Focal neurology 75 33.2
Fits, faints or falls 47 20.8
Non-specific neurological 11 4.9
Other/non-specific 18 8.0
Symptoms and time to diagnosis of brain tumour 3
Downloaded from https://academic.oup.com/fampra/advance-article-abstract/doi/10.1093/fampra/cmx139/4840710
by University of Bristol Library user
on 16 May 2018
Results
There were 226 patients (96.6%) with information on presenting 
symptoms from 234 brain tumour cases. The age distribution was 
bimodal (younger and older) with roughly equal numbers of men 
and women (Table 1) The most common symptom domain was focal 
neurology including stroke (33.2%), followed by episodic attacks—
‘fits, faints or falls’ (20.8%) and headache (20.8%). About 30% of 
cases had experienced three or more consultations prior to referral. 
In around one-third of the cases GPs considered, or were not sure 
if, there had been avoidable delays. In around 20% the GPs felt that 
rapid access to investigations would have been helpful.
The median (interquartile range) of the pathway interval was 
24  days (7–65  days) (Table  2). Younger patients (< 60  years) had 
longer delays on the pathway. There were marked variations in the 
pathway interval by symptom domain. The shortest time was seen 
for episodic attacks – ‘fits, faints or falls’ (10 days) whilst the longest 
interval was seen for memory loss (62 days). Patients who had investi-
gations before referral to specialist care had a longer pathway interval.
Table 2. Median and interquartile range of time to diagnosis (days) by sociodemographic characteristics of patients with a brain tumour
Variable Time to diagnosis
Patient intervala Primary care intervalb Specialist intervalc Pathway intervald
Media n Interquartile 
range
Media n Interquartile 
range
Media n Interquartile 
range
Media n Interquartile 
range
Age group
<60 5.5 0–25.5 3 0–31.5 6 0–19 25.5 8–81
60–69 8 1–26 2 0–6 2 0–12.5 20.5 7–63
>60 5 0–15.5 1 0–15 7 0–24 22 7–54
Sex
Female 5 0–21 1.5 0–13.5 4 0–15 25 7–60.5
Male 8 1–26.5 2 0–15 6 0–17 24 8–66
Ethnicity
White British 6 0–22 2 0–16 4 0–15 24 7–66
Other 6 0–23.5 0 0–7 5 0–25 20 7–60
Housebound
No 7 0–29 1 0–11 6 0–17 25 7–77
Yes 3 0–8 4 0–24 4.5 0–11 15 6–44
Problems in communication
No 7 0–26 2 0–16 4 0–16 25 7–74.5
Yes 2 0–29 0 0–5.5 7 0–16 21.5 7–60
Symptoms
Headache 9 2–45 6 0–30 2 0–11 30 11–86
 Headache only 10 4–101 17.5 5–64 2 0–10 61 20–197
 Headache plus 6 2–18.5 4 0–24 2 0–15 23 7–60
Behavioural/cognitive 14 3–62 4 0–16 9 0–19 39 13–90
 Confusion 16.5 7–31 1.5 0–6 2.5 0–16 18.5 4.5–41
 Memory 14 2–62 5 0–21 11 2–21 62 35–95
Focal neurology 5 0–14 0 0–7.5 9 0–24 21 7–61
Fits, faints or falls 3.5 0–30 0 0–5 0 0–11 10 0–42
Non-specific neurological 12.5 0–28 15 0–35 8 1–17 50 43–65
Other/non-specific 3 0–22 3 0–80 4.5 0–7 16 7–66
Investigation before referral
No 5 0–18 0 0–4 3.5 0–15 14.5 5–50
Yes 13 1–31 11 4–43 7 0–19 55.5 30–110
Type of referral
Emergency 4.5 0–18 0 0–6 0 0–3 14 6–39
Not referred by practice 10 0–22 2 0–6.5 0 0–7 7 0–23
2 week/private 13.5 5–30.5 4 0–16 8 5–11.5 39 15–78
Routine 6 0–33 7 0–80 24.5 12.5–53.5 81 50–141
Which specialist to be referred
A&E 5 0–10 0 0–4 0 0–7 11 7–25
Neurosur/Neurol 8.5 1–26 5 0–33 8 1–19 43.5 10–83
Med/stroke/opth/paeds/miscl 5 0–29 1 0–11 3 0–19 27 8–82
A&E, accident and emergency; Neurosur/neurol, neurosurgery and neurology; Med/stroke/opth/paeds/miscl, medicine and geriatrics, stroke, ophthalmology, 
paediatrics and miscellaneous.
aPatient with missing values (n = 28) are excluded.
bPatient with missing values (n = 45) are excluded.
cPatient with missing values (n = 49) are excluded.
dPatient with missing values (n = 46) are excluded.
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Table 3 shows the ORs and 95% CI for the longest quartile of 
time intervals for each stage of the patient pathway. Compared to ‘fits, 
faints or falls’, headache and the non-specific neurological groups 
showed a significantly elevated OR for the referral (OR  =  6.47, 
95% CI  =  1.22, 34.3 and OR  =  11.9, 95% CI  =  1.82, 77.8, re-
spectively). When we looked at the subgroups, headache only (i.e. 
headache without any other reported features) and memory only, 
they showed larger ORs for the total pathway interval (OR = 4.11, 
95% CI = 1.10, 15.5 and OR = 4.82, 95% CI = 1.15, 20.1, respect-
ively), which was mainly driven by the slower primary care interval 
(OR = 11.8, 95% CI = 1.88, 73.9 and OR = 10.9, 95% CI = 1.79, 
66.1, respectively). GP diagnostic investigations before referral were 
also associated with slower referral and slower overall pathways. 
Unsurprisingly, patients who were referred routinely had longer pri-
mary care and specialist delays, with referral to accident and emer-
gency having shorter patient, specialist and pathway interval. The 
results of non-imputed model are shown in supplementary table 2.
Both headache and behavioural/cognitive changes and 
non-specific symptoms were associated with at least three or more 
presentations before referral (Table  4) and this was most marked 
for headache only (OR = 7.92, 95% CI = 1.80, 34.8) and memory 
complaints (OR = 6.09, 95% CI = 1.30, 28.6). GPs considered that 
Table 3. Odds ratios (OR) and 95% confidence intervals (CI) for slowest quartile time along patient pathway to diagnosis
Time to diagnosis†
Slowest quartile for first 
symptom to first attend 
the GPs
Slowest quartile for first 
attend the GPs to referral
Slowest quartile for referral 
to see the specialist
Slowest quartile for first 
symptoms to see the 
specialist
n/total OR 95% CI n/total OR 95% CI n/total OR 95% CI n/total OR 95% CI
Age groupa
<60 21/84 1.01 0.43–2.35 24/84 2.53 0.98–6.52 20/84 1.74 0.62–4.86 25/84 1.38 0.60–3.19
60–69 14/56 1.00 (reference) 9/56 1.00 (reference) 9/56 1.00 (reference) 14/56 1.00 (reference)
>60 19/86 0.83 0.36–1.91 20/86 1.72 0.66–4.51 26/86 2.46 0.99–6.17 19/86 0.88 0.27–2.12
Sexb
Female 24/105 1.00 (reference) 25/105 1.00 (reference) 25/105 1.00 (reference) 25/105 1.00 (reference)
Male 30/121 1.08 0.54–2.14 28/121 0.96 0.49–1.89 30/121 1.18 0.59–2.35 33/121 1.13 0.60–2.10
Ethnicityc
White British 48/195 1.00 (reference) 48/195 1.00 (reference) 46/195 1.00 (reference) 52/195 1.00 (reference)
Other 7/31 0.92 0.34–2.51 5/31 0.43 0.13–1.40 9/31 1.23 0.47–3.17 6/31 0.61 0.21–1.78
Houseboundd
No 54/196 1.00 (reference) 42/196 1.00 (reference) 48/196 1.00 (reference) 54/196 1.00 (reference)
Yes 1/31 0.10 0.01–0.77 11/31 2.45 0.90–6.69 7/31 0.61 0.18–2.03 4/31 0.42 0.11–1.60
Problems in communicationd
No 48/196 1.00 (reference) 49/196 1.00 (reference) 48/196 1.00 (reference) 52/196 1.00 (reference)
Yes 7/30 0.93 0.32–2.72 4/30 0.44 0.12–1.65 7/30 0.80 0.27–2.37 6/30 0.78 0.25–2.41
Symptomsd
Headache 13/47 1.13 0.39–3.22 15/47 6.47 1.22–34.3 10/47 1.18 0.39–3.61 15/47 2.33 0.80–6.80
 Headache only 6/16 1.96 0.54–7.05 8/16 11.8 1.88–73.9 3/16 0.92 0.18–4.55 7/16 4.11 1.10–15.5
 Headache plus 7/31 0.81 0.23–2.80 8/31 4.54 0.78–26.5 7/31 1.34 0.39–4.54 8/31 1.68 0.50–5.60
Behavioural/cognitive 10/28 1.64 0.55–4.85 7/28 5.41 0.98–29.8 8/28 1.59 0.47–5.37 9/28 2.62 0.77–8.90
 Confusion 3/14 0.97 0.22–4.28 1/14 1.55 0.11–21.3 3/14 1.06 0.17–6.53 2/14 1.13 0.20–6.59
 Memory 6/14 2.55 0.67–9.68 6/14 10.9 1.79–66.1 5/14 2.15 0.52–8.84 7/14 4.82 1.15–20.1
Focal neurology 14/75 0.70 0.26–1.87 14/75 3.37 0.69–16.52 22/75 1.61 0.60–4.31 18/75 1.79 0.62–5.17
Fits, faints or falls 11/47 1.00 (reference) 3/47 1.00 (reference) 9/47 1.00 (reference) 7/47 1.00 (reference)
Non-specific neurological 3/11 0.96 0.16–5.79 5/11 11.9 1.82–77.8 3/11 1.73 0.36–8.45 2/11 1.29 1.96–8.51
Other/non-specific 5/18 1.15 0.27–4.88 7/18 8.23 1.03–66.0 3/18 0.71 0.14–3.60 7/18 3.35 0.89–12.65
Investigation before referrald
No 31/153 1.00 (reference) 20/153 1.00 (reference) 34/153 1.00 (reference) 24/153 1.00 (reference)
Yes 24/73 2.02 1.01–4.03 32/73 5.53 2.62–11.67 21/73 1.33 0.68–2.60 34/73 4.81 2.36–9.79
Type of referrald
Emergency 20/98 1.00 (reference) 16/98 1.00 (reference) 11/98 1.00 (reference) 17/98 1.00 (reference)
Not referred by practice 7/38 0.79 0.24–2.55 5/38 0.70 0.18–2.73 6/38 1.57 0.34–7.22 4/38 0.57 0.17–1.89
2 week/private 13/46 1.56 0.67–3.61 14/46 2.26 0.89–2.73 10/46 2.17 0.74–6.39 13/46 1.78 0.72–4.44
Routine 15/44 2.08 0.86–4.99 18/44 3.67 1.53–8.85 28/44 14.5 5.13–40.8 24/44 5.72 2.26–14.5
Which specialist to be referredd
A&E 3/24 1.00 (reference) 3/24 1.00 (reference) 2/24 1.00 (reference) 1/24 1.00 (reference)
Neurosur/neurol 20/84 2.81 0.53–15.0 28/84 4.35 0.68–27.8 22/84 5.60 0.69–45.6 23/84 7.42 0.83–66.2
Med/stroke/opth/paeds/ 
miscl
33/118 3.82 0.73–19.9 21/118 1.97 0.32–11.9 31/118 5.52 0.69–44.1 34/118 9.45 1.03–87.1
A&E, accident and emergency; Neurosur/neurol, neurosurgery and neurology; Med/stroke/opth/paeds/miscl, medicine and geriatrics, stroke, ophthalmology, 
paediatrics and miscellaneous.
aAdjusted for sex and ethnicity; bAdjusted for age group and ethnicity; cAdjusted for age group and sex; dAdjusted for age group, sex and ethnicity.
†Long time to diagnosis defined as worst quartile of time to diagnosis period.
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faster access to investigations would have helped for both headaches 
and focal neurology symptoms. GPs retrospectively reported that 
there had been avoidable delays for patients presenting with head-
ache only in the patient journey (OR = 3.64, 95% CI = 0.83, 15.9) 
but this was consistent with chance.
Discussion
This is the first study to examine how different symptoms affect 
the patient pathway interval, using a representative sample of brain 
tumour cases from the NACDPC study. We find marked variability 
in time from symptom onset to first specialist attendance for patients 
with brain tumours, depending on their symptoms. Overall, the 
median time from symptom presentation until being seen by a spe-
cialist is <4 weeks. Patients presenting with headaches, behavioural/
cognitive changes or other/non-specific symptoms attended their GP 
more frequently before referral; headache only and memory loss are 
associated with a much slower patient pathway mainly due to delays 
in referral to a specialist (secondary care). In addition, younger 
patients under the age of 60 years and patients over the age 69 also 
tend to experience delays in referral and specialist consultation.
Most previous studies of the diagnostic pathway have focused on 
very specific tumour types, e.g. vestibular schwannoma (20), intradural 
spinal cord tumours (21), pituitary adenomas (21), acoustic neuromas 
(22), central nervous lymphomas (23) or intracranial germ cell tumours 
(24) (e.g. 23,25,26). Similarly, non-specific or more subtle features such 
as personality changes were associated with delayed referral in a case 
series of 58 patients with primary central nervous system lymphoma 
(23,27). Retrospective interviews with patients and relatives can elicit 
prior histories of more subtle problems such as cognitive or personal-
ity change, though these symptoms may be ignored by the patient (9).
The positive predictive value of headache for adult patients with 
brain tumours is low (0.09% overall but 0.12% in 60- to 69-year-
olds) as compared to new-onset seizure (1.2%) (16). Since headache 
is a common complaint, it is difficult for GPs and other doctors to 
differentiate less serious causes of headache from headaches second-
ary to a brain tumour. Headaches associated with brain tumours are 
frequently of ‘tension’ type or mimic migraine (8) and the best clues 
are increasing frequency and severity and headache features (e.g. 
worsening with cough or bending, nocturnal headaches or headaches 
on wakening). The development of additional symptoms e.g. focal 
neurology or signs (papilloedema) will strongly support the diagno-
sis. This underlines the importance that GPs search for the presence 
of additional symptoms, such as behavioural/cognitive changes if 
uncertain as to whether a patient with headache requires investiga-
tions or specialist referral. The use of simple cognitive screening tests, 
such as semantic verbal fluency, may help. This requires assessment of 
how many animals the patient can name in one minute and has been 
previously demonstrated to be worse in brain tumour patients whose 
initial presenting symptom was headache/headache ‘plus’ (28,29).
Strengths and limitations
The study has good generalizability to other high-income health-
care settings, as cases were identified consecutively from primary 
care, without any selection by specialist units. Most studies do not 
prospectively collect data on patient delay, so cannot untangle the 
patient pathway into all its constituent components. However, we 
were forced to group various symptoms into domains to achieve suf-
ficient power due to the sample size. In addition, the reporting of 
potentially avoidable delays and whether further investigation would 
have helped was done retrospectively by the GPs, so may have been 
biased by the actual patient outcomes. For some non-acute features, 
such as behavioural change, patients may have incorrectly reported 
the date of symptom onset. Some patients who had a first-ever pres-
entation directly to accident and emergency departments and were 
hospitalised would have not been included in this dataset, although 
this is not directly relevant to the issue of improving diagnostic 
delay in elective primary care. We included headaches associated 
with ‘nausea’ and ‘vomiting’ (N&V) under the headache plus group 
given the lack of qualifying information in the data available. Ideally, 
though there would be a distinction between N&V seen in common 
conditions such as migraine and ‘atypical’ or ‘red flag’ N&V (such 
as N&V confined to early mornings, or on bending down) which 
alerts the GP to the possibility of more serious pathology—such as a 
brain tumour. We could not look at how presentation and delay were 
associated with type of brain tumour as we did not have data on the 
specific pathology, size and location. This would be of interest as it 
would also be associated with management and prognosis.
Interestingly, GPs considered that more rapid access to investiga-
tions, such as neuroimaging, would have helped, particularly for less 
specific symptoms such as headache (30,31). This important question 
needs to be looked at in terms of cost-effectiveness given the potential 
Table 4. The association between symptom domain and frequent attendance, GP perception of need for rapid access investigations and 
avoidable delay
n/total Attend 3+ times 95% CI Rapid access 
investigations
Avoidable delays
OR n/total OR 95% CI n/total OR 95% CI
Symptomsa
Headache 21/44 4.50 1.39–14.6 18/45 7.27 1.83–28.9 13/46 2.63 0.81–8.59
 Headache only 11/16 7.92 1.80–34.8 11/15 42.77 7.01–261.2 5/16 3.64 0.83–15.9
 Headache plus 10/28 3.27 0.91–11.8 7/30 2.88 0.62–13.4 8/30 2.17 0.59–8.04
Behavioural/cognitive 11/25 4.32 1.18–15.8 5/25 2.02 0.40–10.2 3/27 1.00 0.21–4.67
 Confusion 4/12 2.99 0.61–14.8 0/12 1.00 2/14 1.38 0.22–8.47
 Memory 7/13 6.09 1.30–28.6 5/13 4.13 0.74–23.1 1/13 0.64 0.07–6.29
Focal neurology 22/64 2.71 0.88–8.34 17/68 4.30 1.14–14.1 16/74 2.13 0.70–6.45
Fits, faints or falls 7/36 1.00 (reference) 4/40 1.00 (reference) 6/46 1.00 (reference)
Non-specific neurological 5/11 4.12 0.79–21.4 1/11 1.27 0.11–14.1 3/11 3.59 0.65–19.66
Other/non-specific 10/15 10.17 2.12–48.8 1/14 0.91 0.08–9.86 2/17 0.83 0.14–6.94
aORs adjusted for age group, gender and ethnicity.
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large number of patients that will turn out to have a normal scan. 
Current National Institute for Health and Care Excellence (NICE) 
guidance states ‘Consider an urgent direct access MRI scan of the 
brain (or CT scan if MRI is contraindicated) (to be performed within 
2 weeks) to assess for brain or central nervous system cancer in adults 
with progressive, sub-acute loss of central neurological function.’ (32) 
Patients with only headache or simple memory loss would not in them-
selves be considered to meet these criteria. In addition, there is an impli-
cit assumption that the reduction in the diagnostic interval for patients 
presenting with headaches and memory loss would translate into better 
clinical outcomes, which may or may not be true. Future work should 
examine whether geographical areas with rapid access to neuroimag-
ing have reduced delay in time to diagnosis and whether this translates 
to differences in patient management, morbidity and survival.
Conclusions
Whilst many patients with brain tumours are diagnosed rapidly, GPs 
and other doctors currently face a diagnostic challenge when deciding 
whether to refer patients with headaches and memory complaints. 
Future work needs to identify whether any additional features or 
other simple inexpensive tests could be administered in primary care 
that could help reduce the time to diagnosis in these patients.
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Supplementary data are available at Family Practice online.
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